Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

Press releases published on June 29, 2026

6 hours ago

4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital

Indeterminate GlobeNewswire

6 hours ago

Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

6 hours ago

Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

Indeterminate GlobeNewswire

6 hours ago

4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD

Indeterminate GlobeNewswire

6 hours ago

Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer

Indeterminate GlobeNewswire

6 hours ago

IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper

Indeterminate GlobeNewswire

6 hours ago

Swarmer Adds Additional $1M in Revenue From SkyKnight Contract Update That Expands Swarming Software To Czech Republic

Indeterminate GlobeNewswire

6 hours ago

Roadzen Delivers Best Quarter in Company History with Q4 FY2026 Revenue of $16.1 Million, Up 42% Year-Over-Year; Record Full-Year Revenue of $55.0 Million, Up 24%

Indeterminate GlobeNewswire

6 hours ago

Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

6 hours ago

Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength

Indeterminate GlobeNewswire

6 hours ago

Correction: VivoPower Selects Global AI Industry Leader as Preferred Tenant for Lease of Norway Operational Data Center

Indeterminate GlobeNewswire

7 hours ago

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

Indeterminate GlobeNewswire

7 hours ago

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

Indeterminate GlobeNewswire

7 hours ago

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

Indeterminate GlobeNewswire

7 hours ago

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

Indeterminate GlobeNewswire

7 hours ago

Dyadic Expands IP Protection and Business Development Activities in Japan

Indeterminate GlobeNewswire

7 hours ago

George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations

Indeterminate GlobeNewswire

7 hours ago

Field and Operations Teams Run Daily Work on Custom Power Apps

Indeterminate GlobeNewswire

7 hours ago

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

7 hours ago

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire